Saltar al contenido
Merck

New oligodendrocytes exhibit more abundant and accurate myelin regeneration than those that survive demyelination.

Nature neuroscience (2022-02-16)
Sarah A Neely, Jill M Williamson, Anna Klingseisen, Lida Zoupi, Jason J Early, Anna Williams, David A Lyons
RESUMEN

Oligodendrocytes that survive demyelination can remyelinate, including in multiple sclerosis (MS), but how they do so is unclear. In this study, using zebrafish, we found that surviving oligodendrocytes make few new sheaths and frequently mistarget new myelin to neuronal cell bodies, a pathology we also found in MS. In contrast, oligodendrocytes generated after demyelination make abundant and correctly targeted sheaths, indicating that they likely also have a better regenerative potential in MS.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti-Myelin Proteolipid Protein Antibody, CT, clone PLPC1, clone PLPC1, Chemicon®, from mouse
Sigma-Aldrich
Monoclonal Anti-CNP antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL2887, purified immunoglobulin, buffered aqueous glycerol solution